Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bishop

Showing results (271-280 of 532) with videos related to

Pageof 54
Sort By:
Virology|October 30, 1986
Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3B S Coulson, J M Tursi, W J McAdam, et al.
Health Affairs (Project Hope)|August 7, 2013
Electronic communication improves access, but barriers to its widespread adoption remainTara F Bishop, Matthew J Press, Jayme L Mendelsohn, et al.
Communicable Diseases Intelligence Quarterly Report|November 20, 2014
Australian Rotavirus Surveillance Program annual report, 2012Carl D Kirkwood, Susie Roczo-Farkas, Ruth F Bishop, et al.
The Medical Journal of Australia|November 24, 2011
A case study of a single ethics committee for multicentre trialsIan N Olver, Sharon J P Falleiro, Marion L Marson, et al.
American Journal of Clinical Oncology|June 1, 1997
Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancerM Michael, G C Toner, I N Olver, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II trial of cisplatin and interferon alpha 2b in patients with advanced bladder cancerF X Parnis, I N Olver, T Sandeman, et al.
Neuropharmacology|January 10, 2009
Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effectsHuibing Tan, Stephanie F Bishop, Nicole M Lauzon, et al.
British Journal of Cancer|January 1, 1990
Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancerJ S Cebon, J F Bishop, V Harvey, et al.
The Journal of Biological Chemistry|June 29, 2012
X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2)David F Bishop, Vassili Tchaikovskii, A Victor Hoffbrand, et al.
Australian and New Zealand Journal of Public Health|January 21, 2000
Cost effectiveness of rotavirus vaccination in AustraliaJ B Carlin, T Jackson, L Lane, et al.
Pageof 54

Showing results (271-280 of 532) with videos related to

Sort By:
Pageof 54
Virology|October 30, 1986
Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3B S Coulson, J M Tursi, W J McAdam, et al.
Health Affairs (Project Hope)|August 7, 2013
Electronic communication improves access, but barriers to its widespread adoption remainTara F Bishop, Matthew J Press, Jayme L Mendelsohn, et al.
Communicable Diseases Intelligence Quarterly Report|November 20, 2014
Australian Rotavirus Surveillance Program annual report, 2012Carl D Kirkwood, Susie Roczo-Farkas, Ruth F Bishop, et al.
The Medical Journal of Australia|November 24, 2011
A case study of a single ethics committee for multicentre trialsIan N Olver, Sharon J P Falleiro, Marion L Marson, et al.
American Journal of Clinical Oncology|June 1, 1997
Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancerM Michael, G C Toner, I N Olver, et al.
American Journal of Clinical Oncology|June 1, 1997
A phase II trial of cisplatin and interferon alpha 2b in patients with advanced bladder cancerF X Parnis, I N Olver, T Sandeman, et al.
Neuropharmacology|January 10, 2009
Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effectsHuibing Tan, Stephanie F Bishop, Nicole M Lauzon, et al.
British Journal of Cancer|January 1, 1990
Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancerJ S Cebon, J F Bishop, V Harvey, et al.
The Journal of Biological Chemistry|June 29, 2012
X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2)David F Bishop, Vassili Tchaikovskii, A Victor Hoffbrand, et al.
Australian and New Zealand Journal of Public Health|January 21, 2000
Cost effectiveness of rotavirus vaccination in AustraliaJ B Carlin, T Jackson, L Lane, et al.
Pageof 54